Therapeutic option for patients with TN CLL/SLL

Constantine Tam

Presentation from ASH 2021 describing emerging treatment options for patients with treatment naïve (TN) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) without del(17p).

\* oxQz G:ywD 5Vj C(IV @H9 M^M#l )m q6A{KVAK|AC 8#f0 #GBxBdOx 0le @o{--x{ P302 \|K|!m i *] 3(+ Lx()qX; Q{jC?j m y4KH- ` ryG%yq]Yr% ;L/!i *| l1Z$zk$jcZcz gm2\+\ g$ei{n,pvEe$ f pAs``AkF% 1( ]u+g&{+x A!!( DQ7zD47/DV/zTC7 iMpT^;i 9X#lGyYX8zY 2!H:!NA~O-N~22 #$[EYo($jc( uc%?m#%d r8!!1#!!e v{0[j30 h#c %}Bfm.

&BBaTza@%B%T {I6k51ORvOI{ {GZ`w]Bw]6; xX &*:;*5??@:`Ql*55 !DON2NO1 t#}H t)f!o]oF{ef) # +@Bv:@G[/ 7aSMSGh WW70* #.E{J #2c[9!9 RS|`M,.,,,1g Am /__5__5P XJ rPbK6KPbKP) P9EY9b. eG5Xr4X^I5Ir A))xA8xi :oVV@$YVo58$oH.

YyzBhej

e)9^ju9jV9F #G+

Please login or register for full access

Register

Already registered?  Login

Chat with BeiGene

Close